Exact Mass: 398.24569640000004
Exact Mass Matches: 398.24569640000004
Found 500 metabolites which its exact mass value is equals to given mass value 398.24569640000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mitragynine
Mitragynine itself acts primarily via -opioid receptors, although its oxidation product mitragynine-pseudoindoxyl, which is likely to be a major component of kratom that has been aged or stored for extended periods, acts as a fairly selective -opioid agonist with little affinity for receptors. Another alkaloid with a major contribution to the opioid activity of the kratom plant is the related compound 7-hydroxymitragynine, which while present in the plant in much smaller quantities than mitragynine, is a much more potent opioid agonist. Mitragynine is a monoterpenoid indole alkaloid. Mitragynine is a natural product found in Mitragyna speciosa with data available.
Tris(2-butoxyethyl) phosphate
C18H39O7P (398.24332740000006)
CONFIDENCE standard compound; INTERNAL_ID 610; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10134; ORIGINAL_PRECURSOR_SCAN_NO 10129 CONFIDENCE standard compound; INTERNAL_ID 610; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10034; ORIGINAL_PRECURSOR_SCAN_NO 10029 CONFIDENCE standard compound; INTERNAL_ID 610; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10135; ORIGINAL_PRECURSOR_SCAN_NO 10134 CONFIDENCE standard compound; INTERNAL_ID 610; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10156; ORIGINAL_PRECURSOR_SCAN_NO 10155 CONFIDENCE standard compound; INTERNAL_ID 610; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10080; ORIGINAL_PRECURSOR_SCAN_NO 10079 CONFIDENCE standard compound; INTERNAL_ID 610; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10078; ORIGINAL_PRECURSOR_SCAN_NO 10077 CONFIDENCE standard compound; INTERNAL_ID 2467 CONFIDENCE standard compound; INTERNAL_ID 8244 CONFIDENCE standard compound; INTERNAL_ID 8806
Nandrolone cypionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
Pholcodine
Pholcodine is a Schedule I drug in the US. It is also a class B substance in the United Kingdom although can be purchased over-the-counter in most UK pharmacies. Pholcodine is a drug which is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine. R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
Sunitinib
Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib inhibits cellular signaling by targeting multiple RTKs. These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial growth factor receptors (VEGF-R). Sunitinib also inhibits KIT (CD117), the RTK that drives the majority of GISTs. In addition, sunitinib inhibits other RTKs including RET, CSF-1R, and flt3. C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
Ramipril Diketopiperazine
Ramipril Diketopiperazine is a metabolite of ramipril. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. It is marketed as Prilace by Arrow Pharmaceuticals in Australia, Ramipro by Westfield Pharma in the Philippines, Tritace by Sanofi-Aventis in Italy and United States and Altace by King Pharmaceuticals in the United States, Ramitens by PharmaSwiss, Ampril by Krka in Slovenia, Corpril by Cemelog-BRS in Hungary, Piramil and Prilinda by Hemofarm in Serbia, by Lek in Poland and by Novartis in Bangladesh, and in Canada as Altace (Sonfi) and Ramipril (Pharmascience). (Wikipedia)
Pregnanolone sulfate
C21H34O5S (398.21268340000006)
Pregnanolone sulfate (PAS) belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. Pregnanolone sulfate is an endogenous steroid that inhibits neuron N-methyl-D-aspartate (NMDA) receptors by inducing desensitization of activated NMDA receptors (PMID: 19474309).
Allopregnanolone sulfate
C21H34O5S (398.21268340000006)
Allopregnanolone sulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. Allopregnanolone sulfate has been identified in the human placenta (PMID: 32033212).
(E)-Methyl 2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate
N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
3alpha-Hydroxy-5alpha-pregnan-20-one sulfate
C21H34O5S (398.21268340000006)
Malagashanine
Benzotest
2-(2-(4-(2-Fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)-N,N-diethylacetamide
Variabilin
Variabilin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Variabilin can be found in lentils, which makes variabilin a potential biomarker for the consumption of this food product.
desacetoxyvindoline
Desacetoxyvindoline is a member of the class of compounds known as plumeran-type alkaloids. Plumeran-type alkaloids are alkaloids with a structure based on the plumeran skeleton. Plumeran is a pentacyclic compound that consists of a pyrrolidine ring shed to the quinoline moiety of pyrido[3,2-c]carbazole ring system. Desacetoxyvindoline is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Desacetoxyvindoline can be found in a number of food items such as welsh onion, kiwi, white cabbage, and pecan nut, which makes desacetoxyvindoline a potential biomarker for the consumption of these food products. Desacetoxyvindoline is a terpene idole alkaloid produced by the plant Catharanthus roseus. Desacetoxyvindoline is a product formed by the methylation of the nitrogen on the indole ring by the enzyme 3-hydroxy-16-methoxy-2,3-dihydrotabersonine N-methyltransferase (NMT). The metabolite is a substrate for desacetoxyvindoline 4-hydroxylase (D4H) which catalyzes a hydroxylation to yield deacetylvindoline .
5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-6,10-dienylidene]-4-hydroxy-3-methylfuran-2-one
2-[13-(furan-3-yl)-2,6,10-trimethyltrideca-2,7,9-trienyl]-3-hydroxy-4-methyl-2H-furan-5-one
12-O-beta-D-Glucopyranoside-1beta-3,11(13)-Eudesmadiene-1,12-diol|1beta-hydroxy-beta-costol-12-O-beta-D-glucopyranoside
(20S,22S,23R,24S)-13beta,22:22,25-diepoxy-5-methoxy-14beta-methyl-18-nor-des-A-ergosta-5,7,9,11-tetraen-23-ol|agariblazeispirol B
3-Oxo-24,25,26,27-tetranortirucall-7-en-23,21-olide
(-)-candelalide A|3-[(4aR,6aR,7R,10aR,10bR)-6a,10b-dimethyl-8-methylene-4a,5,6,6a,7,8,9,10a,10b-decahydro-1H-benzo[f]chromen-7-yl]methyl-5,6-dimethyl-2-methoxy-4H-pyran-4-one|3-[[(4aR,6aR,7R,10aR,10bR)-6a,10b-dimethyl-8-methylene-4a,5,6,6a,7,8,9,10,10a,10b-decahydro-1H-benzo[f]chromen-7-yl]methyl]-2-methoxy-5,6-dimethyl-4H-pyran-4-one|Candelalide A
(2R*,4R*)-3,4-dihydro-4,5-dimethyl-8-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-2H-[1]benzopyran-2,7-diol
3-acetoxy-16-methoxy-1,4-dimethyl-6,7-didehydro-21-nor-aspidospermidin-3-ol|Vimdolin
3beta-[(beta-D-glucopyranosyl)oxy]eudesma-4(14),11(13)-dien-12-ol
5-<13-(furan-3-yl)-2,6,10-trimethyltrideca-2,6,8-trienyl>-4-hydroxy-3-methylfuran-2(5H)-one|5-[13-(3-Furanyl)-2, 6, 10-trimethyl-2, 6, 8-tridecatrienyl]-4-hydroxy-3-methyl-2(5H)-furanone|5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-2,6,8-trienyl]-4-hydroxy-3-methylfuran-2(5H)-one
11(S*)-acetoxy-15(S*)-hydroxy-17-chloro-2(R*),12(R*)-epoxy-(3E,7E)-1(S*)-cembra-3,7-diene
C22H35ClO4 (398.22237400000006)
3beta-Sulfooxy-5alpha-pregnanon-(20)|3beta-sulfooxy-5alpha-pregnanone-(20)|3beta5alpha-pregnanolone sulphate|epiallopregnanolone-sulfate|Isopregnanolone sulfate|Sulfat des 3beta-Hydroxy-5alpha-pregnanons-(20)
C21H34O5S (398.21268340000006)
guaia-1,7-dien-3beta,13-diol-13alpha-D-glucofuranoside
ferulic ester of 2-octahydro-3a,7,7,7a-tetramethyl-1-methylene-1-H-indenemethanol
3-heptadecadienyl-3,4-dihydro-8-hydroxyisocoumarin
aspidospermidine-1,3-dicarboxylic acid dimethyl ester|Eburcin
11-methoxystrychnofendlerine|11-Methyoxystrychnofendlerine
1-acetyl-10,11-dimethoxy-4-methyl-3,4-seco-condyfol-14(19)en-3-one|Geissovellin|Geissovelline
14-O-methylryanodanol|6alpha,11alpha-epoxy-14alpha-methoxy-ryanodane-1alpha,5beta,11beta,13beta-pentaol
(E)-1-[3-(4,8-dimethylnona-3,7-dienyl)cyclohex-3-enyl]-2,4,5-trimethoxybenzene
lehualide G
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 3, a hydroxy group at position 4, a methyl group at position 5 and a (2E)-3-methyl-11-phenylundec-2-en-1-yl group at position 6. Isolated from the marine sponge of the genus Plakortis, it exhibits cytotoxicity against human promyeloid leukemic HL-60 cells.
(1R,7R,10S)-11-O-beta-D-glucopyranosyl-4-guaien-3-one
3-oxo-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
A natural product found in Dysoxylum lenticellatum.
3-(hydroxymethyl)-1,14,15-trihydroxy-7,11,15-trimethyl-2,6,10-hexadecatrien-13-yl acetate
3-(hydroxymethyl)-1,13,15-trihydroxy-7,11,15-trimethyl-2,6,10-hexadecatrien-14yl acetate
(20R)-3-Oxo-24,25,26,27-tetranor-5alpha-cycloartan-23,21-olide|3-oxo-24,25,26,27-tetranor-5alpha-cycloartan-23,21-olide|aphagrandinoid D
11-Hydroxy-19-(3-methylbutanoyloxy)-5,7,9(11),13-abietatetraen-12-on
N-((+)-cucurbinoyl)-S-tryptophan|N-<(+)-cucurbinoyl>-S-tryptophan|N-Cucurbinoyltryptophan
Tri(butoxyethyl)phosphate
C18H39O7P (398.24332740000006)
CONFIDENCE standard compound; INTERNAL_ID 4186
2-[5-[2-[2-[5-(2-oxopropyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid
C21H34O7_2(1H)-Naphthalenone, 6-(hexopyranosyloxy)-3,4,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)
PHOLCODINE
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives A morphinane alkaloid that is a derivative of morphine with a 2-morpholinoethyl group at the 3-position. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2-[5-[2-[2-[5-(2-oxopropyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845801]
2-[5-[2-[2-[5-(2-oxopropyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845803]
2-[5-[2-[2-[5-(2-oxopropyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
Ala Ile Pro Val
Ala Ile Val Pro
Ala Leu Pro Val
Ala Leu Val Pro
Ala Pro Ile Val
Ala Pro Leu Val
Ala Pro Val Ile
Ala Pro Val Leu
Ala Val Ile Pro
Ala Val Leu Pro
Ala Val Pro Ile
Ala Val Pro Leu
Gly Ile Ile Pro
Gly Ile Leu Pro
Gly Ile Pro Ile
Gly Ile Pro Leu
Gly Leu Ile Pro
Gly Leu Leu Pro
Gly Leu Pro Ile
Gly Leu Pro Leu
Gly Pro Ile Ile
Gly Pro Ile Leu
Gly Pro Leu Ile
Gly Pro Leu Leu
Ile Ala Pro Val
Ile Ala Val Pro
Ile Gly Ile Pro
Ile Gly Leu Pro
Ile Gly Pro Ile
Ile Gly Pro Leu
Ile Ile Gly Pro
Ile Ile Pro Gly
Ile Leu Gly Pro
Ile Leu Pro Gly
Ile Pro Ala Val
Ile Pro Gly Ile
Ile Pro Gly Leu
Ile Pro Ile Gly
Ile Pro Leu Gly
Ile Pro Val Ala
Ile Val Ala Pro
Ile Val Pro Ala
Leu Ala Pro Val
Leu Ala Val Pro
Leu Gly Ile Pro
Leu Gly Leu Pro
Leu Gly Pro Ile
Leu Gly Pro Leu
Leu Ile Gly Pro
Leu Ile Pro Gly
Leu Leu Gly Pro
Leu Leu Pro Gly
Leu Pro Ala Val
Leu Pro Gly Ile
Leu Pro Gly Leu
Leu Pro Ile Gly
Leu Pro Leu Gly
Leu Pro Val Ala
Leu Val Ala Pro
Leu Val Pro Ala
Pro Ala Ile Val
Pro Ala Leu Val
Pro Ala Val Ile
Pro Ala Val Leu
Pro Gly Ile Ile
Pro Gly Ile Leu
Pro Gly Leu Ile
Pro Gly Leu Leu
Pro Ile Ala Val
Pro Ile Gly Ile
Pro Ile Gly Leu
Pro Ile Ile Gly
Pro Ile Leu Gly
Pro Ile Val Ala
Pro Leu Ala Val
Pro Leu Gly Ile
Pro Leu Gly Leu
Pro Leu Ile Gly
Pro Leu Leu Gly
Pro Leu Val Ala
Pro Pro Ser Val
Pro Pro Val Ser
Pro Ser Pro Val
Pro Ser Val Pro
Pro Val Ala Ile
Pro Val Ala Leu
Pro Val Ile Ala
Pro Val Leu Ala
Pro Val Pro Ser
Pro Val Ser Pro
Ser Pro Pro Val
Ser Pro Val Pro
Ser Val Pro Pro
Val Ala Ile Pro
Val Ala Leu Pro
Val Ala Pro Ile
Val Ala Pro Leu
Val Ile Ala Pro
Val Ile Pro Ala
Val Leu Ala Pro
Val Leu Pro Ala
Val Pro Ala Ile
Val Pro Ala Leu
Val Pro Ile Ala
Val Pro Leu Ala
Val Pro Pro Ser
Val Pro Ser Pro
Val Ser Pro Pro
Pregnanalone sulfate (Allopregnanolone sulfate)
C21H34O5S (398.21268340000006)
(7E)-(1R,3R)-25,26-epoxy-19-nor-9,10-seco-5,7-cholestadien-23-yne-1,3-diol
(5Z,7E,22E,24E)-(1S,3R)-27-nor-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,26-triol
Sunitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
Δ-6 Testosterone Enanthate
25,26-epoxy-1alpha-hydroxy-23,23,24,24-tetradehydro-19-norvitamin D3
1-(2,6-Dihydroxy-4-methoxyphenyl)-6Z,9Z,12Z,15Z-octadecatetraen-1-one
methyl 2-[4-[[4-[(1-methoxy-2-methyl-1-oxopropan-2-yl)amino]phenyl]methyl]anilino]-2-methylpropanoate
Pentagestrone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-[(4-methylphenyl)methyl]- (9CI)
butyl prop-2-enoate,2-ethylhexyl prop-2-enoate,2-methylprop-2-enoic acid
3-methyl-5-[2-phenyl-5-(piperidin-4-ylmethoxy)pyridin-3-yl]-2H-indazole
2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid,hexane-1,6-diol
Lapyrium chloride
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
3-Oxo-24,25,26,27-tetrartirucall-7-en-23,21-olide
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(4-methylphenyl)-N-[(4-methylphenyl)methyl]- (9CI)
enerisant
C22H30N4O3 (398.23177899999996)
Enerisant (TS-091) is a potent, highly selective, competitive and orally active histamine H3 receptor antagonist/inverse agonist with IC50s of 2.89 nM and 14.5 nM against human and rat histamine H3 receptors, respectively[1].
2-(2-(4-(2-Fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)-N,N-diethylacetamide
Flutropium
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
1-[(4-Methylphenyl)methyl]-4-[4-(2-methylphenyl)-1-piperazinyl]pyrazolo[3,4-d]pyrimidine
N-[3-fluoro-4-(4-phenyl-1-piperazinyl)phenyl]-2-(4-morpholinyl)acetamide
1-[(4-Methylphenyl)methyl]-4-[4-(4-methylphenyl)-1-piperazinyl]pyrazolo[3,4-d]pyrimidine
2,3-Diphenyl-N-(2-piperazin-1-ylethyl)furo[2,3-B]pyridin-4-amine
[(2R,3S,4S,5S,7S,8R)-1-[[(2S)-1-amino-3-(carbamoylamino)-1-oxopropan-2-yl]amino]-8-azaniumyl-2,3,5,7,9-pentahydroxy-1-oxononan-4-yl]azanium
5-(13-(3-Furanyl)-2,6,10-trimethyl-6,10-tridecadienylidene)-4-hydroxy-3-methyl-2(5H)-furanone
[3-carboxy-2-[(9E,11E)-13-carboxytrideca-9,11-dienoyl]oxypropyl]-trimethylazanium
C21H36NO6+ (398.25424960000004)
[3-carboxy-2-[(6E,9E)-13-carboxytrideca-6,9-dienoyl]oxypropyl]-trimethylazanium
C21H36NO6+ (398.25424960000004)
[3-carboxy-2-[(2E,4E)-13-carboxytrideca-2,4-dienoyl]oxypropyl]-trimethylazanium
C21H36NO6+ (398.25424960000004)
[(E)-2-[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-hydroxyethenyl] hydrogen sulfate
C21H34O5S (398.21268340000006)
candelalide A
A diterpenoid isolated from Sesquicillium candelabrum and has been shown to act as a blocker of the voltage-gated potassium channel Kv1.3.
4,7-dimethyl-1-propan-2-yl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,5,6,8a-hexahydro-1H-naphthalen-2-one
N-(1-adamantyl)-4-(1,3-benzodioxol-5-yl)-4-hydroxy-1-piperidinecarboxamide
methyl (1S,15S,17S)-17-ethyl-6,7-dimethoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
C22H30N4O3 (398.23177899999996)
(3R)-farnesyl-2,3,5-trimethyl-6-oxido-4-oxocyclohexa-1,5-diene-1-carboxylate
C25H34O4-2 (398.24569640000004)
Cyclohexyl-[4-(2-methyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)-1-piperazinyl]methanone
3-[2-(6,7-dihydroxy-1,2,4a-trimethyl-1-spiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]yl)ethyl]-4-hydroxy-5-methoxy-2-oxolanone
N-[[(2S,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2R,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2S,3R,4R)-1-(cyclobutanecarbonyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-ethylpropanamide
2-cyclopropyl-1-[(2R,3R)-2-(hydroxymethyl)-6-[4-oxanyl(oxo)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-6-[4-oxanyl(oxo)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
1-[(2S,3S)-3-[4-(1-cyclopentenyl)phenyl]-2-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-(2-methylpropyl)acetamide
N-[[(2R,3S,4S)-1-(cyclobutanecarbonyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-ethylpropanamide
(6S,7S,8S)-4-[2-(dimethylamino)-1-oxoethyl]-7-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C22H30N4O3 (398.23177899999996)
2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-6-[4-oxanyl(oxo)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
2-[5-[2-[2-[5-(2-Oxopropyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid
17-Propylestra-1,3,5(10)-triene-3,17beta-diol diacetate
2-[[(2R)-3-decoxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C18H41NO6P+ (398.2671356000001)
2-[hydroxy-[(2R)-2-hydroxy-3-nonanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C17H37NO7P+ (398.23075220000004)
4-[[4-(dimethylamino)phenyl]methyl]-1-methyl-2-phenyl-4a,8a-dihydro-4H-pyrazolo[1,5-a]indol-1-ium-6-ol
2-[(3-Decoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C18H41NO6P+ (398.2671356000001)
2-[Hydroxy-(2-hydroxy-3-nonanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C17H37NO7P+ (398.23075220000004)
3alpha-Hydroxy-5beta-pregnane-20-one sulfate
C21H34O5S (398.21268340000006)
(3R)-farnesyl-2,3,5-trimethyl-6-oxido-4-oxocyclohexa-1,5-diene-1-carboxylate
An oxo monocarboxylic acid anion that is the a dianion resulting from the carboxy group and the beta-keto-enol group of 3-farnesyl-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylic acid; major species at pH 7.3.
methyl (2e)-2-[(2s,3s,12br)-3-ethyl-8-methoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
5-{10-[6-(methoxycarbonyl)pyridin-3-yl]decyl}pyridine-2-carboxylic acid
7-[2-(2-hydroxypropyl)-3,6,8-trimethyl-7-oxo-5,6,8,8a-tetrahydro-1h-naphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoic acid
15-hydroxy-6-(2-hydroxy-5-oxohex-3-en-2-yl)-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
4-chloro-2-[(2e)-7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl]-5-methylbenzene-1,3-diol
C22H35ClO4 (398.22237400000006)
4-[(3e,7e)-4,8-dimethyl-11-[(3z)-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]undeca-3,7-dien-1-yl]-5h-furan-2-one
(4ar,6r,8as)-4,8a-dimethyl-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one
1-(2,6-dihydroxy-4-methoxyphenyl)octadeca-6,9,12,15-tetraen-1-one
5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-7,9-dien-1-ylidene]-4-hydroxy-3-methylfuran-2-one
methyl 2-[(1r,9r,12r,19r)-8-acetyl-6-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-12-yl]acetate
[3-(1,2-dihydroxyethyl)-3-(hydroxymethyl)-4a,7,10a-trimethyl-octahydro-1h-naphtho[2,1-b]pyran-7-yl]methyl acetate
3,4a-dimethyl-3-(2,4,6-trimethyl-8-phenylocta-4,6-dien-1-yl)-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one
3-chloro-4,6-dimethoxy-2-pentadecylphenol
C23H39ClO3 (398.25875740000004)
(1'r,3r,4s,10'r,11'r,12's)-5'-methoxy-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2',4',6',8'-tetraen-3-ol
2-methoxy-3,5-dimethyl-6-[(1r,6s)-1,3,5-trimethyl-6-[(2e,4r)-4-methyl-5-oxohept-2-en-2-yl]cyclohexa-2,4-dien-1-yl]pyran-4-one
(2e,4e,6e,8e,10e)-13-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2,7,11-trimethyl-12-oxotrideca-2,4,6,8,10-pentaenal
2-methoxy-3,5-dimethyl-6-[(1s,4s,5r,6s)-1,3,6-trimethyl-4-[(2e,4r)-4-methyl-5-oxohept-2-en-2-yl]bicyclo[3.1.0]hex-2-en-6-yl]pyran-4-one
4-[(3z,7e)-4,8-dimethyl-11-[(3z,5s)-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]undeca-3,7-dien-1-yl]-5h-furan-2-one
2-{[(1r,2s,4as,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(acetyloxy)phenyl acetate
13-(1-hydroxy-2,2,6-trimethyl-4-oxocyclohexyl)-2,6,11-trimethyltrideca-2,4,6,8,10,12-hexaenoic acid
(6z,9z,12z,15z)-1-(2,6-dihydroxy-4-methoxyphenyl)octadeca-6,9,12,15-tetraen-1-one
(5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl)methyl 3-methylbutanoate
(1r,4s,7s)-7-[(1e,3e,5z,7e,9s,10e)-9-hydroxy-6,8,10-trimethyldodeca-1,3,5,7,10-pentaen-1-yl]-4,6,6,7-tetramethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
2-{[4-hydroxy-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1-{7-hydroxy-8-methoxy-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9-trien-5-yl}propan-1-one
methyl (1r,5r,7r,8r,9r,12r,13s)-14-acetyl-4,9-dimethyl-10-oxa-4,14-diazapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carboxylate
(4ar)-7-hydroxy-2,2-dimethyl-4a,8-bis(3-methylbut-2-en-1-yl)-6-(2-methylpropanoyl)chromen-5-one
n-(2-hydroxy-1-{[(2s)-1-[(2r)-2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopent-4-en-2-yl]-c-hydroxycarbonimidoyl}ethyl)-6-methylheptanimidic acid
(8e)-6-ethyl-1,7-dihydroxy-13-methoxy-3,7,9,11-tetramethyl-5,14-dioxabicyclo[11.2.1]hexadec-8-ene-2,4-dione
[(2r,3ar,7ar)-3a,7,7,7a-tetramethyl-1-methylidene-tetrahydro-2h-inden-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(5s)-5-[(2z,6e,10e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,6,10-trien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one
14-epi-neovibsanin g
{"Ingredient_id": "HBIN001453","Ingredient_name": "14-epi-neovibsanin g","Alias": "NA","Ingredient_formula": "C25H34O4","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(=C)C)C)C","Ingredient_weight": "398.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15466","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11188728","DrugBank_id": "NA"}
acetyl-alstohentine
{"Ingredient_id": "HBIN014446","Ingredient_name": "acetyl-alstohentine","Alias": "NA","Ingredient_formula": "C23H30N2O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "310","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,2e,6e,10s)-10-isopropyl-3,7-dimethylcyclodeca-2,6-dien-1-yl (2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate
6-{3a,6,6,9a-tetramethyl-2,7-dioxo-hexahydro-1h-cyclopenta[a]naphthalen-3-ylidene}-2-methylhepta-2,4-dienoic acid
(1's,2s,3s,3'r,5r,7'r,11'r)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)-12'-oxospiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-diene-10'-carboxylic acid
10-isopropyl-3,7-dimethylcyclodeca-2,6-dien-1-yl 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate
n-[2-(diethylamino)ethyl]-5-{[(3z)-5-fluoro-2-hydroxyindol-3-ylidene]methyl}-2,4-dimethyl-1h-pyrrole-3-carboximidic acid
(3r,4ar,7ar)-3,4a-dimethyl-3-[(2s,4e,6e)-2,4,6-trimethyl-8-phenylocta-4,6-dien-1-yl]-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one
(2e,4e,6e,8e,10e,12e)-13-[(1r,6s)-1-hydroxy-2,2,6-trimethyl-4-oxocyclohexyl]-2,6,11-trimethyltrideca-2,4,6,8,10,12-hexaenoic acid
2-methoxy-3,5-dimethyl-6-[1,3,5-trimethyl-6-(4-methyl-5-oxohept-2-en-2-yl)cyclohexa-2,4-dien-1-yl]pyran-4-one
(1'r,2s,3r,4s,10'r,11'r,12's)-5'-methoxy-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2',4',6',8'-tetraen-3-ol
[(1s,4as)-5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl]methyl 3-methylbutanoate
(1s,2r,3s,6s,7s,8s,9s,12r,13r)-9,12,13-trihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl acetate
(2z)-2-[(6e,10e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-6,10-dien-1-ylidene]-5-hydroxy-4-methylfuran-3-one
(3r,4'r,6'r,7's,8'ar)-7'-[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-6'-ethyl-4'-methyl-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-4'-ium-2-olate
(1r,3s,6s,7r,8e,11r,13r)-6-ethyl-1,7-dihydroxy-13-methoxy-3,7,9,11-tetramethyl-5,14-dioxabicyclo[11.2.1]hexadec-8-ene-2,4-dione
2-methoxy-3,5-dimethyl-6-[1,3,6-trimethyl-4-(4-methyl-5-oxohept-2-en-2-yl)bicyclo[3.1.0]hex-2-en-6-yl]pyran-4-one
4,8a-dimethyl-6-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one
(3ar,4s,7r)-1,4-dimethyl-7-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-3a,4,5,6,7,8-hexahydro-3h-azulen-2-one
2-methoxy-3,5-dimethyl-6-[(1r,6s)-1,3,5-trimethyl-6-[(2e,4s)-4-methyl-5-oxohept-2-en-2-yl]cyclohexa-2,4-dien-1-yl]pyran-4-one
(1e)-2-[(1s,5s,7r,8s,11s)-8-methyl-5-(2-oxopropyl)-11-(prop-1-en-2-yl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
1-[(1r,4r,12r,16s)-7-hydroxy-8-methoxy-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9-trien-5-yl]propan-1-one
5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-6,10-dien-1-ylidene]-4-hydroxy-3-methylfuran-2-one
(1'r,2r,3r,4s,10'r,11'r,12's)-5'-methoxy-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2',4',6',8'-tetraen-3-ol
(5r)-5-[(2z,6s,7e,9e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,7,9-trien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one
2-(hydroxymethyl)-6-{[7-(3-hydroxyprop-1-en-2-yl)-4a-methyl-1-methylidene-octahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol
(1'r,2s,3r,4s,10's,11'r,12's)-5'-methoxy-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2',4',6',8'-tetraen-3-ol
5-(3-hydroxy-2-methylprop-1-en-1-yl)-3,3',14'-trimethyl-12'-oxospiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-diene-10'-carbaldehyde
(2e,4e)-6-[(3z,3as,5ar,9ar,9bs)-3a,6,6,9a-tetramethyl-2,7-dioxo-hexahydro-1h-cyclopenta[a]naphthalen-3-ylidene]-2-methylhepta-2,4-dienoic acid
8-hydroxy-2-{3-hydroxy-3-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]propyl}-6-methylocta-2,6-dien-1-yl acetate
(2z,6z)-8-hydroxy-2-[(3s)-3-hydroxy-3-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]propyl]-6-methylocta-2,6-dien-1-yl acetate
n-[(1s)-2-hydroxy-1-{[(2s)-1-[(2r)-2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopent-4-en-2-yl]-c-hydroxycarbonimidoyl}ethyl]-6-methylheptanimidic acid
7-[7-hydroxy-3,6,8-trimethyl-2-(2-oxopropyl)-1,5,6,7,8,8a-hexahydronaphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoic acid
(5z)-5-[(2r,6r,7e,9e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-7,9-dien-1-ylidene]-4-hydroxy-3-methylfuran-2-one
8-hydroxy-5b,9,9,11a-tetramethyl-2-(penta-1,3-dien-1-yl)-5,5a,6,7,8,9a,10,11-octahydro-1,12-dioxatetraphen-4-one
2-methoxy-3,5-dimethyl-6-[(1s,4s,5r,6s)-1,3,6-trimethyl-4-[(2z,4r)-4-methyl-5-oxohept-2-en-2-yl]bicyclo[3.1.0]hex-2-en-6-yl]pyran-4-one
methyl (2e)-2-{3-ethyl-8-methoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}-3-methoxyprop-2-enoate
(2r,5s,6s,9r,13s,15s)-15-hydroxy-6-[(2s,3e)-2-hydroxy-5-oxohex-3-en-2-yl]-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
methyl (2e)-2-[(2s,3r,12bs)-3-ethyl-8-methoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
(6s)-6-[(1r,3r,4s,8r,11s,12r,14s)-3-hydroxy-5-(hydroxymethyl)-1,12-dimethyl-15-oxapentacyclo[9.3.1.0³,⁸.0⁴,¹⁴.0⁸,¹²]pentadeca-5,9-dien-9-yl]-2-methylhept-2-en-4-one
2-[8-methyl-5-(2-oxopropyl)-11-(prop-1-en-2-yl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
4-[(3e,7e)-4,8-dimethyl-11-[(3e,5s)-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]undeca-3,7-dien-1-yl]-5h-furan-2-one
(2e,4e,6e)-7-[(1r,6r,8s,8as)-2-[(2s)-2-hydroxypropyl]-3,6,8-trimethyl-7-oxo-5,6,8,8a-tetrahydro-1h-naphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoic acid
7-hydroxy-2,2-dimethyl-4a,8-bis(3-methylbut-2-en-1-yl)-6-(2-methylpropanoyl)chromen-5-one
(1e)-2-[(1s,5s,7r,8s,11r)-8-methyl-5-(2-oxopropyl)-11-(prop-1-en-2-yl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
(2r,5s,9r,13s,15s)-15-hydroxy-6-[(2s,3e)-2-hydroxy-5-oxohex-3-en-2-yl]-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
methyl (2r)-2-[(2r,4as,7s,8ar)-4a-methyl-8-methylidene-7-[(3-phenylpropanoyl)oxy]-octahydronaphthalen-2-yl]propanoate
methyl (2z)-2-[(2s,3s,12br)-3-ethyl-8-methoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
4-[(3e,7e)-4,8-dimethyl-11-[(3z,5r)-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]undeca-3,7-dien-1-yl]-5h-furan-2-one
(5r)-5-[(2e,4e,10e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,4,10-trien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one
5-[(2e,6z,10e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,6,10-trien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one
(1's,2s,3s,3'r,5r,7'r,9'e,11'r)-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]-3,3',14'-trimethyl-12'-oxospiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-diene-10'-carbaldehyde
(1'r,2s,3s,3'r,5r,7'r,9'e,11'r)-11'-hydroxy-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)-12'-oxospiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-diene-10'-carbaldehyde
(1'r,2r,3r,4s,10's,11'r,12's)-5'-methoxy-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2',4',6',8'-tetraen-3-ol
6,7-dimethoxy-8-[(7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-yl)oxy]-2-methyl-3,4-dihydro-1h-isoquinoline
methyl 2-{8-acetyl-6-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-12-yl}acetate
methyl (2z)-2-[(2s,3r,12bs)-3-ethyl-8-methoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
(5z)-5-[(2s,6e,10e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-6,10-dien-1-ylidene]-3-hydroxy-4-methylfuran-2-one
8-acetyl-5-methoxy-13,16-dimethyl-12-oxa-8,16-diazapentacyclo[8.8.3.0¹,⁹.0²,⁷.0¹⁴,²¹]henicosa-2,4,6-trien-19-one
6,7-dimethoxy-8-[(6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-yl)oxy]-2-methyl-3,4-dihydro-1h-isoquinoline
(5z)-5-[(2s,6s,7e,9e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-7,9-dien-1-ylidene]-4-hydroxy-3-methylfuran-2-one
(1s,9s,10r,13r,14s,21r)-8-acetyl-5-methoxy-13,16-dimethyl-12-oxa-8,16-diazapentacyclo[8.8.3.0¹,⁹.0²,⁷.0¹⁴,²¹]henicosa-2,4,6-trien-19-one
(5z)-5-[(6e,8e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dien-1-ylidene]-4-hydroxy-3-methylfuran-2-one
2-({1-hydroxy-2-[3-hydroxy-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)-3-(1h-indol-3-yl)propanoic acid
(2e,4e)-2-{2-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl}-5-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]penta-2,4-dienal
(5r)-5-[(2e,7e,9e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,7,9-trien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one
4-chloro-2-(7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl)-5-methylbenzene-1,3-diol
C22H35ClO4 (398.22237400000006)